Postprandial glucose and vascular disease

Diabetic Medicine

Volumn 14, Issue SUPPL. 3, 1997, Pages

  Haller, H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Diabetes; Endothelial cells; Glucose; Protein kinase C

Indexed keywords

GLUCOSE; PROTEIN KINASE C;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMANS; HYPERGLYCEMIA; PERMEABILITY; POSTPRANDIAL PERIOD; PROTEIN KINASE C; SERUM ALBUMIN;

EID: 0030740122     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199708)14:3+3.0.CO;2-1     Document Type: Article

References (70)

1. Diabetes in America: Diabetes Data Compiled 1984, 1985. NIH publication no. 85-1468. National Institutes of Health, 1984.
2. Health Care Financing Administration Research Report, End Stage Renal Disease. Publication 03274. Baltimore: Office of Research and Demonstration, 1985 (1987).
3. West KM. Epidemiology of Diabetes and its Vascular Lesions. New York: Elsevier Science Publishing Co. Inc., 1978: 579-612.
4. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 1974; 23: 105-111.
5. Lüscher TF, Vanhoutte PM. The Endothelium: Modulator of Cardiovascular Function. Boca Raton: CRC Press, 1990.
6. Dzau VJ, Gibbons GH. Cell biology of vascular hypertrophy in systemic hypertension. Am J Cardiol 1988; 62: 30G-35G.
7. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; i: 997-1000.
8. Lüscher TF. Imbalance of endothelium-derived relaxing and contracting factors: a new concept in hypertension? Am J Hypertens 1990; 3: 317-330.
9. Yanagisawa M, Kurihara H, Kimura S, Mitsiu Y, Kobayashi M, Watanabe TX, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 388: 411-415.
10. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27.
11. DiCorleto PE, Fox PL. Growth factor production by endothelial cells. In: Una R, ed. Endothelial Cells, vol. 2. Boca Raton: CRC Press, 1988; 51-62.
12. Egleme C, Creesier F, Wood JM. Local formation of angiotensin II in the rat aorta. Effect of endothelium. Br J Pharmacol 1990; 100: 237-240.
13. Palmer RJM, Ashtor DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-666.
14. Lorenzi M, Cagliero E. Pathobiology of endothelial and other vascular cells in diabetes mellitus; call for data. Diabetes 1991; 40: 653-659.
15. Jensen T, BJerre-Knudsen J, Feldt-Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989; 1: 461-463.
16. Guerra R, Brotherton AFA, Goodwin PJ, Clark CR, Armstrong ML, Harrison DG. Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: implications for altered autocrine and paracrine functions of EDRF. Blood Vessels 1989; 26: 300-314.
17. Yang Z, Richard V, von Segesser L, Stulz P, Turina M, Lüscher TF. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. A new mechanism of vasospasm. Circulation 1990; 82: 188-195.
18. 2 formation and platelet sensitivity to prostacyclin in insulin-dependent and independent diabetics. Thromb Res 1982; 26: 359-370.
19. Williams E, Timperley WR, Ward JD, Duckworth T. Electron microscopic studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 1980; 33: 462-470.
20. Simionescu M, Simionescu N. Functions of the endothelial cell surface. Ann Rev Physiol 1986; 48: 279-304.
21. Vracko R. A comparison of the microvascular lesions in diabetes mellitus with those of normal ageing. J Am Ceriatr Soc 1982; 30: 201-205.
22. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 1986; 314: 488-500.
23. MeraJi S, Jayakody L, Senaratne MP, Thompson AB, Kappagoda T. Endothelium-dependent relaxation in aorta of BB rat. Diabetes 1987; 36: 978-981.
24. Williamson JR, Wolf BA, Ostrow E, Turk J. Relationship of glucose-induced vascular function changes to diacylglycerol (DAG) levels and protein kinase C (PKC) activity. Diabetes 1990; 93: 157A.
25. Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 1991; 87: 31-38.
26. Tesfamariam B, Brown ML, Cohen RA. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 1991; 87: 1643-1648.
27. Tesfamariam B, Brown ML, Deykin D, Cohn RA. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 1990; 85: 929-932.
28. Lamping KG, Dole WP. Acute hypertension selectively potentiates constrictor responses of large coronary arteries to serotonin by altering endothelial function in vivo. Circ Res 1987; 61: 901-913.
29. Yamouchi T, Ohnaka K, Takayanagi R, Umeda F, Nawata H. Enhanced secretion of endothelin-1 by elevated glucose levels from cultured bovine aortic endothelial cells. FEBS Lett 1990; 267: 16-18.
30. Berk BC, Alexander RW, Brock TA, Gimbrone MA, Webb RC. Vasoconstriction-a new role for platelet-derived growth factor. Science 1986; 232: 87-90.
31. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990; 70: 427-451.
32. Ignarro LJ. Physiology and pathophysiology of nitric oxide. Kidney Int 1996; 55: S2-S5.
33. Butkus A, Srinska VA, Schumacher OP. Thromboxane production and platelet aggregation in diabetic subJects with clinical complications. Thromb Res 1980; 19: 211-223.
34. Scharf RE, Harker LA. Thrombosis and atherosclerosis: regulatory role of interactions among blood components and endothelium. Blut 1987; 55: 131.
35. Springer TA. The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Annu Rev Cell Biol 1990; 6: 359-402.
36. Haller H, Schaper D, Philipp S, Distler A. LDL induces surface expression of adhesion molecules 1CAM-1 and VCAM on endothelial cells via the activation of protein kinase C. J Am Soc Nephrol 1992; 3: 456.
37. Gilcrease MZ, Hoover RL. Examination of monocyte adherence to endothelium under hyperglycemic conditions. Am J Pathol 1991; 139: 1089-10907.
38. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 1988; 82: 735-738.
39. Cagliero E, Roth T, Roy S, Lorenzi M. Characteristics and mechanisms of high-glucose-induced over expression of basement membrane components in cultured human endothelial cells. Diabetes 1991; 40: 102-110.
40. Roy S, Sala R, Cagliero E, Lorenzi M. Over expression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci USA 1990; 87: 404-408.
41. Morrison AD, Clements RS Jr, Travis SB, Oski F, Winegrad AI. Studies of the effects of an elevated glucose concentration on the ultrastructure and composite metabolism of the intact rabbit aortic intima-media preparation. Diabetes 1979; 28: 720-723.
42. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988; 318: 1315-1321.
43. Winegrad AI. Does a common mechanism induce the diverse complications of diabetes? Diabetes 1987; 6: 396-406.
44. Lee TS, Saltsman KA, Ohashi H, King GL. Activation of protein kinase C by elevated glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci USA 1989; 86: 5141-5145.
45. Tooke JE. Microvascular function in human diabetes. A physiological perspective. Diabetes 1995; 44: 721-726.
46. Wardle EN. Vascular permeability in diabetics and implications for therapy. Diabetes Res Clin Pract 1994; 23: 135-139.
47. Nannipieri M, Rizzo L, Rapuano A, Pilo A, Penno G, Navalesi R. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care 1995; 88: 1-9.
48. Sander B, Larsen M, Engler C, Lund Andersen H, Parving HH. Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol Copenh 1972; 5: 553-559.
49. Yamashita T, Mimura K, Umeda F, Kobayashi K, Hashimoto T, Nawata H. Increased transendothelial permeation of albumin by high glucose concentration. Metabolism 1995; 44: 739-744.
50. Williams B. Glucose-induced vascular smooth muscle dysfunction: the role of protein kinase C. J Hypertens 1995; 13: 477-486.
51. Derubertis FR, Craven PA. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 1994; 43: 1-8.
52. Williams B, Tsai P, Schrier RW. Glucose-induced downregulation of angiotensin II and arginine vasopressin receptors in cultured rat aortic vascular smooth muscle cells. Role of protein kinase C. J Clin Invest 1992; 90: 1992-1999.
53. Haller H, Baur E, Quass P, Behrend M, Lindschau C, Distler A, et al. High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells. Kidney Int 1995; 47: 1057-1067.
54. Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol 1994; 267: L223-L241.
55. Lynch JJ, Ferro TJ, Blumenstock FA, Brockenauer AM, Malik AB. Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest 1990; 85: 1991-1998.
56. Haller H, Ziegler W, Lindschau C, Luft FC. Endothelial cell tyrosine kinase receptor and G-protein coupled receptor activation involves distinct protein kinase C isoforms. Arterioscler Thromb Vase Biol 1996; 16: 678-686.
57. Murray MA, Heistad DD, Mayhan WG. Role of protein kinase C in bradykinin-induced increases in microvascular permeability. Circ Res 1991; 68: 1340-1348.
58. 2. Am J Physiol 1989; 256: H1012-H1022.
59. Siflinger-Birnboim AM, Goligorsky S, Vecchio PJ, Malik AB. Activation of protein kinase C pathway contributes to hydrogen peroxide induced increase in endothelial cell permeability. Lab Invest 1992; 67: 24-30.
60. Northover AM, Northover BJ. Lectin-induced increase in microvascular permeability to colloidal carbon in vitro may involve protein kinase C activation. Agents Actions 1994; 41: 136-139.
61. Stanimirovic DB, Bertrand N, McCarron R, Uematsu S, Spatz M. Arachidonic acid release and permeability changes induced by endothelins in human cerebromicro-vascular endothelium. Acta Neurochir 1994; 60 (suppl): 71-75.
62. Fassano A, Fiorentini C, Donelli G, Uzzau S, Kasper JB, Margaretten K, et al. Zonula occludens toxin modulates tight Junctions through protein kinase C-dependent actin reorganization, in vitro. J Clin Invest 1995; 96: 710-720.
63. Studer RK, Craven PA, DeRubertis FR. Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes 1993; 42: 118-126.
64. Fumo P, Kuncio CS, Ziyadeh FN. PKC and high glucose stimulate collagen alpha 1(IV) transcriptional activity in a reporter mesangial cell line. Am J Physiol 1994; 267: F632-F638.
65. Alkon DL, Rasmussen HA. Spatial-temporal model of cell activation. Science 1988; 239: 998-1005.
66. Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hormann A, et al. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner ProJect. Diabetologia 1996; 39: 1540-1545.
67. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995; 28: 103-117.
68. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979; 2: 131-141.
69. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kudama M, Kubota M, et al. Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia 1995; 38: 585-591.
70. UK Prospective Diabetes Study Group. UK Prospective Study (UKPDS) VIII. Study design, progress and performance. Diabetologia 1991; 34: 877-890.